Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant
Pediatric Blood & Cancer · 2026-06 · 73 (6)
DOI: 10.1002/1545-5017.70259 ↗Kurz gefasst
Klinische Studie (Phase II) in der Zeitschrift Pediatric Blood & Cancer, online erschienen am 23.03.2026. Verfasst von Kristen L Votruba und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Vorinostat, Hematopoietic Stem Cell Transplantation, Quality of Life, Histone Deacetylase Inhibitors. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NCI NIH HHS, NIH National Cancer Institute.
Abstract (Originalsprache)
Purpose
Cognitive and psychological difficulties could negatively interfere with treatment adherence and quality of life before and after hematopoietic stem cell transplant (HSCT). Methods to mitigate these changes may have positive effects on treatment success. Prior work has shown that histone deacetylases (HDAC) inhibitors such as vorinostat show promise in reducing the incidence of graft‐versus‐host disease (GVHD) in allogenic transplant recipients and may mitigate some of the cognitive changes seen following transplant in adults. The current work presents a planned secondary analysis of a phase I/II trial of vorinostat for GVHD prophylaxis (NCT03842696) to establish a cognitive and psychological safety profile for use of this emerging therapeutic in a sample of children, adolescents, and young adults.
Methods
Thirty‐two allogeneic transplant recipients (median age = 19) were evaluated with cognitive and health‐related quality‐of‐life (HRQL) measures prior to transplant and at 100 days and 180 days after transplant ( N = 25 (cognitive) and 25 (HRQL) at final endpoint). Kolmogorov–Smirnov tests and linear mixed effects modeling were used to compare cognitive performances and HRQL to normative levels and to examine changes over time.
Results
Notable cognitive impairments prior to transplant remained relatively stable throughout the first 180 days post‐transplant, with no new neurocognitive safety signal over 180 days. Anxiety was apparent at baseline, but behavioral symptoms remained relatively well managed.
Conclusion
Results highlight cognitive impairments present prior to transplant and support prior findings in an adult population, suggesting that vorinostat does not result in additional cognitive or psychological deficits following transplant.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
- School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Pediatrics, Indiana University, Indiana, Bloomington, USA.
- Pediatric Hematology-Oncology, Henry Ford Health Center, Detroit, Michigan, USA.
- Department of Pediatrics, Aflac Center for Cancer and Blood Disorders, Emory University, Atlanta, Georgia, USA.
ORCID-Profile: April Rahrig, Carrie L Kitko
Förderung
- NHLBI NIH HHS
- NCI NIH HHS
- NIH National Cancer Institute
- NIH National Heart, Lung, and Blood Institute
Zitieren
APA
Votruba, K. L., Rozwadowski, M., Braun, T., Rahrig, A., Peres, E., Williams, K. M., Fabrizio, V., Talano, J. A., Kitko, C. L., Parnell, N., Reddy, P., & Choi, S. W. (2026). Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant. Pediatric Blood & Cancer, 73(6). https://doi.org/10.1002/1545-5017.70259
Vancouver
Votruba KL, Rozwadowski M, Braun T, Rahrig A, Peres E, Williams KM, et al. Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant. Pediatric Blood & Cancer. 2026;73(6). doi:10.1002/1545-5017.70259
BibTeX
@article{Votruba2026,
author = {Votruba, Kristen L and Rozwadowski, Michelle and Braun, Thomas and Rahrig, April and Peres, Edward and Williams, Kirsten M and Fabrizio, Vanessa and Talano, Julie-An and Kitko, Carrie L and Parnell, Nicolas and Reddy, Pavan and Choi, Sung Won},
title = {Cognitive Functioning in Vorinostat‐Treated Pediatric and Young Adult Patients Over the First 180 Days After Hematopoietic Stem Cell Transplant},
journal = {Pediatric Blood & Cancer},
year = {2026},
volume = {73},
number = {6},
doi = {10.1002/1545-5017.70259}
}
EUVIMED